US Supreme Court overturns Federal Circuit patent exhaustion stance in Impression v Lexmark
The US Supreme Court has ruled that patents rights in a product are exhausted after sale in the US or internationally, in a decision that included some strongly-worded pushback of the Federal Circuit. Pharmaceutical companies could be particularly affected because of their downstream licensing models
The Supreme Court has ruled for Impression Products on both issues in its case against Lexmark. The Impression Products v Lexmark decision provides greater protection for downstream customers and expands patent exhaustion.
The Supreme Court on May 30 ruled that...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.